The Cooper Companies, Inc. logo
The Cooper Companies, Inc. (COO)
Compare

The Cooper Companies, Inc. (COO) Price CAGR:-4.24%(TTM)

Compare

Over the latest trailing 12-month period, The Cooper Companies, Inc. (COO)'s price cagr is -4.24%. The comparable SPY value is +22.87%. Year-to-date price return is -16.31%. Price CAGR uses adjusted close price history and excludes dividends.

Over longer horizons, The Cooper Companies, Inc.'s Price CAGR averages -8.63% over 3 years and -6.26% over 5 years. The price CAGR (Compound Annual Growth Rate) shows how The Cooper Companies, Inc.'s stock price has grown over various time periods. This measures pure price appreciation without including dividends.

COO Price CAGR Chart

The Cooper Companies, Inc. (COO)

COO Quarterly Price (YoY)

Price growth vs the same quarter one year earlier, last 20 quarters.

COO Price CAGR History

YearStart PriceEnd PriceChange% ChangeCAGR
202587.3073.02-14.28-16.36%-16.36%
202495.1387.30-7.83-8.23%-8.23%
202380.5295.13+14.61+18.14%+18.14%
202299.1180.52-18.59-18.76%-18.76%
202169.1599.11+29.96+43.33%+43.33%
202082.1169.15-12.96-15.78%-15.78%
201958.5082.11+23.61+40.36%+40.36%
201861.5558.50-3.05-4.96%-4.96%
201741.6561.55+19.90+47.78%+47.78%
201643.6141.65-1.96-4.49%-4.49%
201533.7543.61+9.86+29.21%+29.21%
201429.4633.75+4.29+14.56%+14.56%
201319.9029.46+9.56+48.04%+48.04%
201219.2419.90+0.66+3.43%+3.43%
201110.2319.24+9.01+88.07%+88.07%
20106.7210.23+3.51+52.23%+52.23%
20099.536.72-2.81-29.49%-29.49%
200813.609.53-4.07-29.93%-29.93%
200711.0113.60+2.59+23.52%+23.52%
200615.7911.01-4.78-30.27%-30.27%
200514.2515.79+1.54+10.81%+10.81%
20048.4114.25+5.84+69.44%+69.44%
20036.038.41+2.38+39.47%+39.47%
20025.796.03+0.24+4.15%+4.15%
20014.625.79+1.17+25.32%+25.32%
20002.844.62+1.78+62.68%+62.68%
19994.552.84-1.71-37.58%-37.58%
19982.834.55+1.72+60.78%+60.78%
19971.612.83+1.22+75.78%+75.78%

Quarterly Price: QoQ & YoY

QuarterValueQoQYoY
Q2 202668-3.0%-2.6%
Q1 202670-14.9%-16.4%
Q4 202582+21.7%-10.6%
Q3 202568-3.1%-38.8%
Q2 202570-16.7%-20.2%
Q1 202584-9.0%-17.8%
Q4 202492-16.7%-1.5%
Q3 2024110+26.4%+34.2%
Q2 202487-14.3%-6.4%
Q1 2024102+9.1%+9.1%
Q4 202393+13.5%+13.7%
Q3 202382-11.8%+24.7%
Q2 202393-0.1%+15.8%
Q1 202393+13.7%-9.4%
Q4 202282+24.5%-17.0%
Q3 202266-18.1%-38.2%

QoQ = change vs the prior quarter; YoY = change vs the same quarter a year earlier.

About The Cooper Companies, Inc.

The Cooper Companies, Inc. (COO) operates as a global medical device firm, primarily focused on developing, producing, and distributing products through two distinct business units: CooperVision and CooperSurgical. CooperVision specializes in contact lenses. Their product range includes spherical lenses for common vision issues like nearsightedness and farsightedness, as well as advanced lenses such as toric for astigmatism, multifocal for presbyopia, and specialized options addressing myopia, dry eyes, and eye fatigue. These vision correction solutions are available across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. Meanwhile, CooperSurgical is dedicated to women's and family health, providing a wide array of medical devices, fertility treatments, genetic testing, diagnostic tools, and contraceptives to healthcare providers and patients globally. This segment's offerings encompass various surgical and office-based products like PARAGARD (an IUD), uterine manipulators, retractors, and closure devices. It also delivers comprehensive fertility services, including specialized consumables, equipment, embryo services, and preimplantation genetic screening. Established in 1958, The Cooper Companies, Inc. is headquartered in San Ramon, California.

San Ramon, CA
16,000 employees
Healthcare / Medical - Instruments & Supplies
Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
Albert G. White